Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06019832

Analysis of Varus Collapse in Obese Patients With Stem and Non-Stem Tibial Components Following Primary Total Knee Arthroplasty

The purpose of this study is to compare rates of varus collapse, aseptic loosening, and implant failure in female obese patients undergoing total knee arthroplasty (TKA) and will review the degree of influence of stemmed tibial components versus non-stemmed tibial components on varus collapse and aseptic loosening, a consequence of implant micromotion.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

40 year–99 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Iowa Health Care Medical Center North Liberty

North Liberty, Iowa, 52317, United States

About this study

The purpose of this study is to identify varus collapse, aseptic loosening, and implant failure in female obese patients undergoing total knee arthroplasty (TKA). In addition, this study will review the degree of influence of stemmed tibial components versus non-stemmed tibial components on varus collapse and aseptic loosening, a consequence of implant micromotion.

Female patients age 40 and older with BMI of 35 kg/m2 and above will be randomized into two groups: the non-stem tibial component (control group) and the stem tibial component (treatment group). Previous studies done in the past in normal weight patients showed that there is little or no advantage in using the stem tibial implants over the non-stem ones. Theoretically, biomechanical studies have suggested that there may be improved fixation and load distribution with the use of stem tibial implants. Thus, it is necessary to see if there is any difference between both implant options among female patients who have the highest incidence of varus collapse. In terms of design, the stem tibial implants are slightly longer than the non-stem ones. They are designed to extends deeper into the tibia to enhance fixation and improve load distribution. The use of either stem tibial implants is usually based on patients' characteristics and surgeons' preference.

Following informed consent, standard perioperative patient-reported metrics will be collected (Knee Injury and Osteoarthritis Outcome Score for Joint Replacement [KOOS-JR], American Knee Society score, and Patient-Reported Outcome Measurement Information System 10 [PROMIS-10]) before surgery and after surgery (2-3 weeks, 8-10 weeks, 1 year, 3 years, and 5 years). After surgery, study participants will receive routine surgical care which includes two knee radiographs at 8-10 weeks and one year. In addition to this, the study participants will be evaluated at 3 years, and 5 years postoperative periods where they will complete routine PROMs as listed above and have knee radiographs during each visit.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female adult patients with severe osteoarthritis scheduled to have primary total knee arthroplasty
  • Age 40 or older
  • 35 kg/m2 and above
  • Only patients from the PI's clinic will be included.
  • Women who are still menstruating and are currently on contraceptives and women who are in menopause.

Exclusion criteria

  • Patients who have some active local or widespread infection (including secondary or inflammatory osteoarthritis)
  • medical conditions that put them at risk of complications or death during and after the study would not be eligible for surgery
  • Patients with previous knee surgery on arthroplasty site will be excluded
  • Pregnant patients and women who are capable of getting pregnant

Treatment and study plan

Total knee arthroplasty (TKA)

Procedure

Both study arms will undergo TKA

Stemmed Tibial Implant

Device

A stemmed tibial implant.

Non-stemmed tibial implant

Device

A non-stemmed tibial implant.

Primary outcomes

  1. Varus Collapse

    Time frame: up to 5 years post surgery

    The investigators will track rate of varus collapse.

  2. Aseptic loosening

    Time frame: up to 5 years post surgery

    The investigators will track rates of aseptic loosening.

Sponsors and collaborators

Lead sponsor

Jacob M. Elkins

Other

Registry information

Acronym: SvNS

Important dates

Study start
2023
Primary completion
2032
Study completion
2032
First posted
Aug 31, 2023
Registry last updated
May 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.